The RISE (Rare Disease) Selling Framework

About the Book

The RISE (Rare Disease) Selling Framework, 2nd Edition, a companion to The RISE (Rare Disease) Leadership Framework, distinguishes itself in a crowded field of selling models by emphasizing long-term impact, deep insights, and genuine transformation rather than just short-term transactional or persuasive tactics. What makes it unique is its tailored approach for commercial teams specializing in rare diseases. It aligns with the missions of life sciences organizations by placing patients at the center of every interaction. This non-linear framework addresses the specific challenges of selling within the rare disease sector through four core pillars: Readiness, Inspiration, Signals, and Energizer. The RISE (Rare Disease) Selling Framework, 2nd Edition, empowers talented commercial teams with transferable skills to break traditional boundaries and become stronger voices for patients with rare diseases. It’s more than just a strategy—it’s a mindset shift. RISE. It’s a New Day. Are you Ready?

About the Author

Peter W. Carbone is the founder and CEO of Mindset Effect Consulting, LLC. He has approximately three decades of experience in life sciences industries, spanning fields such as leadership, operations, marketing, and learning and development. His life sciences industry experience serves as the foundation for The RISE (Rare Disease) Selling Framework, 2nd Edition, designed for territory managers, and The RISE (Rare Disease) Leadership Framework, developed for first-line leaders and Learning & Development Business Partners within the rare disease sector. For additional information on how Mindset Effect Consulting may be able to support your organization, visit www.MindsetEffectConsulting.com or send an email to Carbone@MindsetEffectConsulting.com. Testimonial: “Peter’s experience and passion in Learning & Development, leading, coaching, and selling in the rare disease sector serve as a unique combination that can bring immense value to your organization.” Mart Byford, Rare Disease leader and Learning & Development business partner.